当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Saroj Jain, Neha Sharma, Raj Kumar Sharma, Anupama Diwan
The objective of this research work was to prepare a chrono- modulated drug delivery system to meet chronopharmacological needs of asthma. In this study doxofylline was selected as a model drug. To meet this objective an initial lag phase of release for 3-5 hrs and later a rapid (surge) release phase was considered. To achieve surge release a rapidly releasing core tablet of doxofylline was developed by admixing doxofylline with effervescent granules and super disintegrants. The lag phase in release (2hr) was achieved by coating EV core tablets with release retarding polymers Eudragit RS-100 6% containing HPMC (Hydroxy Propyl Methyl Cellulose) 5%, further over coated with enteric polymer CAP (Cellulose Acetate Phthalate) 12%. The formulated chronomodulated tablets of doxofylline were able to release more than 90% drug within 4 hrs after the lag phase of 2 hrs.